DIOD PAO

DIOD PAO Equity Ratio

The Equity Ratio of DIOD PAO (DIOD.ME) as of Nov 20, 2026 is 84.05 %. In the previous year, Equity Ratio was 85.13 % — a change of -1.27% (lower).

Equity Ratio

84.05 %

YoY

-1.27%

Last updated:

Equity Ratio of DIOD PAO is 2023 84.05 % . Equity Ratio of DIOD PAO was 2022 85.13 % . It decreases by -1.27% lower compared to the previous year.

The DIOD PAO Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2016
84.77 RUB
Jan 1, 2017
83.00 RUB
Jan 1, 2018
82.68 RUB
Jan 1, 2019
83.67 RUB
Jan 1, 2020
86.49 RUB
Jan 1, 2021
86.97 RUB
Jan 1, 2022
85.13 RUB
Jan 1, 2023
84.05 RUB
The DIOD PAO Equity Ratio history
YEAREquity RatioYoY
84.05 %-1.27%
85.13 %-2.12%
86.97 %+0.55%
86.49 %+3.37%
83.67 %+1.19%
82.68 %-0.38%
83.00 %-2.09%
84.77 %+11.23%
76.21 %+14.68%
66.45 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DIOD PAO Stock analysis

What does DIOD PAO do? DIOD PAO generates revenue through the manufacturing and sale of pharmaceuticals, dietary supplements, medical cosmetic products, and medical equipment. Its product portfolio includes iodine, selenium, and calcium-based vitamins, as well as silver water purifiers and light therapy apparatus. The company serves healthcare providers, consumers, and medical centers like Mir ekologii, which it owns, through its subsidiaries and affiliated companies. Revenue streams are derived from direct sales of these products and services to end-users and healthcare institutions. The company's main focus is on eco-friendly and natural-based products, targeting consumers seeking health and wellness solutions. Its subsidiaries and affiliated companies facilitate distribution across various segments, including pharmaceuticals, dietary supplements, and medical equipment. The firm's medical center Mir ekologii complements its product offerings by providing healthcare services that align with its natural health focus. DIOD PAO's revenue model relies on the production and sale of its branded products, such as iodine, selenium, and calcium-based vitamins, which are sold through its subsidiaries. The medical equipment segment, including silver water purifiers and light therapy apparatus, contributes to its revenue through direct consumer and institutional sales. The ownership of Mir ekologii allows the company to integrate healthcare services with its product portfolio, enhancing customer retention and cross-selling opportunities. DIOD PAO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DIOD PAO stock

Equity Ratio of DIOD PAO is 84.05 % in 2023.

Equity Ratio of DIOD PAO changed from 85.13 % to 84.05 %, representing a -1.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio DIOD PAO since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's DIOD PAO with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — DIOD PAO

All Key Metrics — DIOD PAO